Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Quattro74on Apr 04, 2020 8:25pm

53 Views

Post# 30879841

RE:RE:RE:RE:RE:RE:Dr Fauci IS THE PROBLEM

Thanks Doc,

I think with the studies that are out there for HCQ we should have some decent efficacy data. What the FDA decides to do will be interesting. I've got my fingers crossed they'll approve it for earlier use.

Hempdoc wrote:

Hi Quattro...Good question.

I don't think there will be a "silver bullet" drug or a "single-drug" treatment for this virus in the "latter" stages of illness. However, I see a lot of potential as a possible single-drug prophylactic (post exposure), or perhaps given as single-drug treatment within a very short timeframe after onset of "milder" symptoms, especially in lower-risk populations.

Studies indicate that RNA viruses (like CV-19) tend to get less virulent "over time", especially after many rounds of mutation. The virus's innate ability to rapidly mutate can be a double-edged sword, & what was once its advantage (the rapid ability to mutate) eventually becomes its downfall...until a new virus shows off its "novel" armor in humans.